Leishmania donovani p36(LACK) DNA Vaccine Is Highly Immunogenic but Not Protective against Experimental Visceral Leishmaniasis

The acquisition of immunity following subclinical or resolved infection with the intracellular parasite Leishmania donovani suggests that vaccination could prevent visceral leishmaniasis (VL). The LACK (Leishmania homolog of receptors for activated C kinase) antigen is of interest as a vaccine candi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Melby, Peter C., Yang, Jue, Zhao, Weiguo, Perez, Luis E., Cheng, Jun
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2001
Materias:
Microbial Immunity and Vaccines
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC98557/
https://ncbi.nlm.nih.gov/pubmed/11447143
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.69.8.4719-4725.2001
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares